Study Suggests New Way to Screen Infants for Fetal Alcohol Syndrome
New study published in The Journal of Pediatrics
Cincinnati, OH, March 5, 2008 — Children who have been diagnosed with Fetal Alcohol Syndrome (FAS) are more likely to have serious psychiatric and behavioral problems later in life, including a higher risk for dropping out of school, unemployment, and criminal behavior. Studies have shown that early intervention is a key element in minimizing the negative effects of FAS. Unfortunately, the early diagnosis of FAS is not always possible, especially if certain physical characteristics are not present. However, a study scheduled for publication in The Journal of Pediatrics suggests a new way to diagnose infants affected by FAS.
Dr. Jennifer Peterson, currently at the Cleveland Clinic, and colleagues from Rainbow Babies and Children’s Hospital, Case Western Reserve University, and the Mary Ann Swetland Center for Environmental Health, studied a group of 216 infants whose mothers drank various amounts of alcohol during pregnancy. The levels of fatty acid ethyl esters (FAEE), which are produced when alcohol is broken down in the digestive system, were measured in the first bowel movement of the newborns. The babies were then given developmental tests at the ages of six months, one year, and two years.
Infants with higher levels of FAEE in their first bowel movement were found to be at risk for developmental disorders. According to Dr. Peterson, “Increasing levels of FAEE were significantly associated with poorer mental and psychomotor development during the first two years of life.” She also notes that “early intervention for such at risk children could minimize disabilities and improve developmental outcomes.” Measuring the levels of FAEE in an infant’s first bowel movement could be a useful method for identifying children at risk for FAS, which may make early intervention possible.
The study is reported in “Fatty Acid Ethyl Esters in Meconium are Associated with Poorer Neurodevelopmental Outcomes to Two Years of Age” by Jennifer Peterson, MD, H. Lester Kirchner, PhD, Wei Xue, MS, Sonia Minnes, PhD, Lynn T. Singer, PhD, and Cynthia F. Bearer, MD, PhD. The article appears in The Journal of Pediatrics, DOI 10.1016/j.jpeds.2007.11.009, published by Elsevier.
The Journal of Pediatrics is a primary reference for the science and practice of pediatrics and its subspecialties. This authoritative resource of original, peer-reviewed articles oriented toward clinical practice helps physicians stay abreast of the latest and ever-changing developments in pediatric medicine. The Journal of Pediatrics ranks 4th of 74 pediatric journals receiving the most citations (Science Citation Index). URL: www.jpeds.com
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.